Based on the clinical manifestations, the results of brain MRI, and levels of Aβ42, P-tau, and T-tau in the CSF, the patient was diagnosed with AD with parkinsonian and psychiatric features (Fig. 1A, 1C). The gene discussed is MAPT; the disease is Alzheimer disease.